QRG Capital Management Inc. Sells 112,826 Shares of Cardinal Health, Inc. $CAH

QRG Capital Management Inc. lowered its stake in Cardinal Health, Inc. (NYSE:CAH) by 78.5% during the 3rd quarter, Holdings Channel reports. The firm owned 30,886 shares of the company’s stock after selling 112,826 shares during the quarter. QRG Capital Management Inc.’s holdings in Cardinal Health were worth $4,848,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in CAH. SJS Investment Consulting Inc. increased its holdings in shares of Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the last quarter. Atlantic Edge Private Wealth Management LLC boosted its stake in Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares during the last quarter. Vermillion & White Wealth Management Group LLC grew its holdings in Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after buying an additional 71 shares in the last quarter. American Capital Advisory LLC grew its holdings in Cardinal Health by 5,200.0% during the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after buying an additional 208 shares in the last quarter. Finally, NewSquare Capital LLC increased its stake in Cardinal Health by 100.0% in the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after acquiring an additional 107 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent earnings and guidance support continued upside — Cardinal beat EPS and revenue last quarter and set FY‑2026 guidance of $9.65–$9.85, which underpins bullish analyst commentary and sentiment.
• Positive Sentiment: Analyst upgrade and higher price target — Wells Fargo raised its price target to $237 and kept an “overweight” rating, signaling institutional confidence and an ~11.6% upside vs. current levels. Wells Fargo raises PT to $237
• Positive Sentiment: Momentum: 52-week high and positive coverage — Zacks notes CAH reached a 52‑week high and highlights fundamentals that could sustain the run, supporting momentum traders. Cardinal Health Hit a 52 Week High
• Neutral Sentiment: Income/dividend profile noted — A TalkMarkets dividend analysis flags CAH as a major distributor with dividend appeal for income investors, but it’s not a near-term price catalyst. Dividend Stock Analysis: Cardinal Health, Inc.
• Neutral Sentiment: Multiple Zacks pieces highlight CAH for earnings-beat potential and strong interest coverage — useful context for investors but not an immediate trigger. Will Cardinal Beat Estimates Again?
• Neutral Sentiment: General market/quote pages note price action — coverage from Globe and Mail and Economic Times provides market/quote context but no new company developments. Analysts Offer Insights on Healthcare Companies
• Negative Sentiment: Profit-taking and valuation concerns pushing a pullback — after the 52‑week high and analyst hype, investors appear to be trimming positions; intraday volume is below average and the stock carries a relatively rich P/E (~32) and other metrics (negative trailing ROE) that may prompt caution.

Cardinal Health Stock Down 0.5%

NYSE CAH opened at $212.44 on Monday. Cardinal Health, Inc. has a 52 week low of $120.72 and a 52 week high of $215.48. The firm has a market capitalization of $50.48 billion, a price-to-earnings ratio of 32.04, a PEG ratio of 1.48 and a beta of 0.65. The company has a fifty day moving average of $205.37 and a two-hundred day moving average of $174.80.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same quarter last year, the business earned $1.88 EPS. The business’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Friday, January 2nd. Cardinal Health’s payout ratio is 30.77%.

Analyst Ratings Changes

A number of research firms have recently commented on CAH. UBS Group increased their target price on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Wells Fargo & Company upped their price target on shares of Cardinal Health from $221.00 to $237.00 and gave the company an “overweight” rating in a research note on Thursday. Citigroup upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $190.00 to $244.00 in a research report on Friday, January 9th. Argus lifted their price objective on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research note on Tuesday, November 4th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Fourteen research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $216.33.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.